Pepe M

Department of Psychiatry, Fondazione Policlinico Universitario “A. Gemelli” IRCCS , ,

7 papers · ORCID

ArticleKetamine

The association between anhedonia and quality of life in treatment-resistant depression: effects of a three-month treatment with esketamine nasal spray

Marcelli I, Pepe M, Specogna E +8

Europe PMC2026
ArticlePsilocybin

Mycelium Growth and Development of <i>Psilocybe</i> spp. Mother Cultures on Agar-Based Media.

Pepe M, Hesami M, Fleishmann L +2

Europe PMC2025
ArticleKetamine

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Di Nicola M, Pepe M, d'Andrea G +26

Europe PMC2025
ArticleKetamine

Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report.

Moccia L, Bartolucci G, Pepe M +10

Europe PMC2024
ArticleKetamine

The Patient's Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression.

Pepe M, Bartolucci G, Marcelli I +9

Europe PMC2023
ArticlePsilocybin

A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.

Pepe M, Hesami M, de la Cerda KA +3

Europe PMC2023
ArticleKetamine

Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series.

Pepe M, Bartolucci G, Marcelli I +4

Europe PMC2023